Knowledge, attitude and practice towards multiple myeloma among medical staff in Enshi Region

Knowledge, attitude and practice towards multiple myeloma among medical staff in Enshi Region

Abstract A study in the Enshi Region between Sept-Nov 2023 assessed medical staff’s knowledge, attitude, and practice regarding multiple myeloma. The disease significantly impacts physical health, quality of life, and mental well-being. Medical professionals play crucial roles in its prevention and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Luping Zou, Jinhua Li, Hang Xiang, Jun Tan, Yan Zeng
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-01-01
Series:	Scientific Reports
Subjects:	Knowledge Attitude Practice Medical staff Multiple myeloma Enshi Region
Online Access:	https://doi.org/10.1038/s41598-025-88079-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effects of Different Tea Varieties on the Quality of Enshi Yulu Tea
by: WANG Huanhuan, QIN Muxue, HU Xingming, YUAN Liping, QIN Xinxue, YU Zhi, ZHENG Shibing, ZHANG Qiang, NI Dejiang, CHEN Yuqiong
Published: (2024-12-01)

Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by: Kara I. Cicero, et al.
Published: (2025-01-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01)

Prognostic correlation analysis of multiple myeloma based on HALP score of peripheral blood before chemotherapy
by: CHEN Min, et al.
Published: (2025-01-01)

Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study
by: Matthew A. Lee, et al.
Published: (2025-01-01)

Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis
by: Xuejie Gao, et al.
Published: (2025-01-01)

Detection of new single nucleotide polymorphisms in plasma cells carcinoma (myeloma) by polymerase chain reaction–single strand conformation polymorphism and sequencing technical methods
by: Sarah K. Obayes, et al.
Published: (2024-01-01)

Metabolomics approach reveals key plasma biomarkers in multiple myeloma for diagnosis, staging, and prognosis
by: Xiaoxue Wang, et al.
Published: (2025-02-01)

The association between the dietary inflammatory index and multiple myeloma: a case–control study
by: Hoda Zahedi, et al.
Published: (2025-01-01)

Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis
by: Kate Tokareva, et al.
Published: (2025-01-01)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)

Chemotherapy plus therapeutic plasmapheresis with 4% human albumin solution in multiple myeloma patients with acute kidney injury: a prospective, open-label, proof-of-concept study
by: Tianzhi Wu, et al.
Published: (2024-12-01)

Evaluation of plasma cell sorting methods in multiple myeloma patients: flow cytometry versus magnetic beads
by: Yu Jeong Choi, et al.
Published: (2025-01-01)

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment
by: Halina Urbanska-Rys, et al.
Published: (2003-01-01)

Guillain-Barré syndrome in patients with multiple myeloma: three cases report and literature review
by: Zhichao Li, et al.
Published: (2025-01-01)

Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group
by: Anna Waszczuk-Gajda, et al.
Published: (2020-04-01)

Knowledge, Attitudes, and Practices of ICU Medical Staff toward Nutrition Care and its Impact on Patient Recovery in Taiz, Yemen
by: Haitham T. S. Mohammed, et al.
Published: (2024-12-01)

Prognostic signature based on mitochondria- and angiogenesis-related genes associated with immune microenvironment of multiple myeloma
by: Dai Zhang, et al.
Published: (2025-12-01)

Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
by: Rahul Navab, et al.
Published: (2025-01-01)

A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecast
by: Qianru Hou, et al.
Published: (2025-01-01)

Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding
by: Rajni Saijpaul, et al.
Published: (2023-01-01)

Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
by: Fang Ye, et al.
Published: (2024-04-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

Predictive factors of thrombosis during autologous stem cell transplantation in multiple myeloma: Experience from EHU Oran (Algeria)
by: Mohammed Amine BEKADJA, et al.
Published: (2022-06-01)

Predictive factors of thrombosis during autologous stem cell transplantation in multiple myeloma: Experience from EHU Oran (Algeria)
by: Mohammed Amine BEKADJA, et al.
Published: (2022-06-01)

CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
by: Ugo Testa, et al.
Published: (2024-10-01)

Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects
by: Ada Alice Dona, et al.
Published: (2025-01-01)

Outcomes of Idecabtagene Vicleucel Therapy in Patients with Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience
by: Aaron Trando, et al.
Published: (2024-12-01)

Detection of early relapse in multiple myeloma patients
by: Tereza Růžičková, et al.
Published: (2025-01-01)

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
by: Ka-Won Kang, et al.
Published: (2025-02-01)

Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study)
by: Annemarie Glöckner, et al.
Published: (2025-01-01)

GDF15-mediated enhancement of the Warburg effect sustains multiple myeloma growth via TGFβ signaling pathway
by: Wenjing Xue, et al.
Published: (2025-01-01)

Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma Patients
by: Eva Plakoula, et al.
Published: (2025-01-01)

Targeting deubiquitinase USP7-mediated stabilization of XPO1 contributes to the anti-myeloma effects of selinexor
by: Junying Wang, et al.
Published: (2025-01-01)

Prognostic model and immune-infiltrating cell landscape based on differentially expressed autophagy-related genes in TP53-mutated multiple myeloma
by: Yan-Hua Zheng, et al.
Published: (2021-07-01)

A multiscale model of the bone marrow and hematopoiesis
by: Ariosto Silva, et al.
Published: (2011-03-01)

More than meets the eye: Nocardia farcinica, Candida dubliniensis and Aspergillus spp. co-infection in a patient with multiple myeloma treated with multiple treatment regimens
by: Lotte Vrijders, et al.
Published: (2025-02-01)

Targeting Caveolin‐1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell‐Mediated Immunotherapy
by: Dewen Zhan, et al.
Published: (2025-01-01)

5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
by: Weiwei Xie, et al.
Published: (2024-12-01)